371 related articles for article (PubMed ID: 9360512)
1. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women.
Khorram O; Yeung M; Vu L; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3590-6. PubMed ID: 9360512
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
3. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men.
Khorram O; Vu L; Yen SS
J Gerontol A Biol Sci Med Sci; 1997 Jan; 52(1):M1-7. PubMed ID: 9008662
[TBL] [Abstract][Full Text] [Related]
4. The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system.
Khorram O; Garthwaite M; Golos T
J Clin Endocrinol Metab; 2001 Jul; 86(7):3157-61. PubMed ID: 11443181
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
7. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
[TBL] [Abstract][Full Text] [Related]
8. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
11. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
12. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes of neuro-endocrine-immune interactions in healthy humans.
Mazzoccoli G; Correra M; Bianco G; De Cata A; Balzanelli M; Giuliani A; Tarquini R
J Biol Regul Homeost Agents; 1997; 11(4):143-7. PubMed ID: 9582614
[TBL] [Abstract][Full Text] [Related]
14. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1993 Jan; 76(1):134-8. PubMed ID: 8421077
[TBL] [Abstract][Full Text] [Related]
16. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales AJ; Nolan JJ; Nelson JC; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
[TBL] [Abstract][Full Text] [Related]
17. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
degli Uberti EC; Ambrosio MR; Cella SG; Margutti AR; Trasforini G; Rigamonti AE; Petrone E; Müller EE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
20. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
